HARMONY organized an interactive session at the 1st European Alliance for Personalised Medicine Congress (EAPM2017) which took place from 27-30 November 2017 at The Belfast Waterfront in Belfast, Northern Ireland. EAPM is a HARMONY Partner.
The HARMONY session title was: Big data in hematology; accelerating more efficient drug development, regulatory evaluation, access appraisal and treatment strategies
Date/Time: November 28, 2017 | 17:30 – 19:00 hrs.
Speakers:
About EAPM
EAPM brings together European healthcare experts, patient advocates involved with chronic diseases, industry, researchers, academics, and cross-party Members of the European Parliament (among others). Its aim is to improve patient care by accelerating the development, delivery and uptake of personalized medicine and diagnostics, through consensus building.
Download the EAMP Congress report here >
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
